跳至主要内容
临床试验/NCT06589024
NCT06589024进行中(未招募)不适用

Remote STATE Training for Insomnia in Older Adults - Phase II

Posit Science Corporation1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2025年1月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
240
试验地点
1
主要终点
Sleep Efficiency

研究概览

简要总结

This study called rSTATE (Remote STATE Training for Insomnia in Older Adults) is a Phase II study to definitively evaluate the efficacy of a computerized cognitive training program (rSTATE) designed to improve sleep regulation and brain health and extend functional independence in older adults with insomnia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants who are 65 years of age or older. The inclusion age of ≥ 65 is in accordance with the FDA's Guideline for Industry Studies in Support of Special Populations (Geriatrics ICH-E7), which uses 65 as its cutoff for defining the geriatric population prone to insomnia.
  • Participants who have an Insomnia disorder diagnosis per DSM-V.
  • Participants who exhibit > 30 minutes sleep onset latency (SOL); and/or > 30 minutes wake after sleep onset (WASO).
  • Participants must be a US resident.
  • Participants who are fluent English speakers, per self-report, to ensure reasonable neuropsychological results on key assessments.
  • Participants must have adequate sensorimotor capacity to perform the program, including visual capacity adequate to read from a computer screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a computer mouse or a tablet.

排除标准

  • Participants who score ≥ 4 on the Cognitive Function Index (CFI).
  • Participants who self-report vision or hearing difficulties that would interfere with the ability to complete the study tasks.
  • Participants with past or present psychosis, schizophrenia, or bipolar disorder. Participants with other untreated psychiatric disorder, including substance abuse/dependence disorders.
  • Participants with a seizure disorder.
  • Participants with untreated obstructive sleep apnea, diagnosis of other sleep disorders not attributable to a primary sleep regulation problem (e.g., restless legs syndrome).
  • Participants with a recent hospitalization, ongoing chemotherapy or other cancer treatment.
  • Participants enrolled in a concurrent clinical trial involving an investigational pharmaceutical, nutraceutical, medical device, or behavioral treatment (CBTi) in the last 12-months that could affect the outcome of this study, or concurrent engagement in another insomnia treatment, per self-report. However, participation in standard treatments not known to affect sleep (e.g., occupational therapy) or use of prescribed medications (e.g., anti-depressants) is allowable if stable on medications for > 3 months.
  • Participants who are using computer-based cognitive training programs or have used it within a month of the consent date.

研究组 & 干预措施

Experimental Treatment

Experimental

Computerized plasticity-based adaptive cognitive training requiring a total maximum of 36 treatment sessions, up to 5 sessions per week, ~36 minutes per session.

干预措施: Computerized Plasticity-Based Adaptive Cognitive Training (Other)

Active Comparator

Active Comparator

Sleep hygiene education

干预措施: Sleep Hygiene Education (Other)

结局指标

主要结局

Sleep Efficiency

时间窗: At 9 weeks and at 6 months

次要结局

  • Wake After Sleep Onset(At 9 weeks and at 6 months)
  • Sleep Onset Latency(At 9 weeks and at 6 months)
  • Total Sleep Time(At 9 weeks and at 6 months)
  • Total Time in Bed(At 9 weeks and at 6 months)
  • Total Wake Time(At 9 weeks and at 6 months)
  • Sleep Quality(At 9 weeks and at 6 months)
  • Patient Health Questionnaire - 8 questions (PHQ-8) Score(At 9 weeks and at 6 months)
  • Generalized Anxiety Disorder Questionnaire - 7 questions (GAD-7) Score(At 9 weeks and at 6 months)
  • Percentage of Time Spent in Stage N1 Sleep(At 9 weeks)
  • Percentage of Time Spent in Stage N2 Sleep(At 9 weeks)
  • Percentage of Time Spent in Stage N3 Sleep(At 9 weeks)
  • Percentage of Time Spent in REM Sleep(At 9 weeks)
  • REM Latency(At 9 weeks)
  • Gradual-Onset Continuous Performance Task Score(At 9 weeks and at 6 months)
  • Complex Set-Shifting Score(At 9 weeks and at 6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验